Mechanistic insights into concurrent cART + 3HP therapy in TB/HIV co-infection
TB and HIV remain two of the world’s deadliest infections, and their convergence creates a uniquely difficult clinical challenge. Our study in rhesus macaques uncovers how early concurrent cART and 3HP therapy shapes immunity, bacterial control, and the risk of TB reactivation.
